BioStem Technologies (OTCMKTS:BSEM) Trading 5.1% Higher – Here’s What Happened

BioStem Technologies, Inc. (OTCMKTS:BSEM)’s stock price was up 5.1% during mid-day trading on Friday . The company traded as high as $5.89 and last traded at $5.80. Approximately 29,118 shares traded hands during trading, a decline of 85% from the average daily volume of 193,572 shares. The stock had previously closed at $5.52.

BioStem Technologies Price Performance

The firm has a 50-day moving average of $4.96 and a 200 day moving average of $5.54. The company has a market capitalization of $97.55 million, a PE ratio of 6.82 and a beta of -0.38.

BioStem Technologies (OTCMKTS:BSEM) last announced its quarterly earnings results on Thursday, November 13th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.02 by $0.01. The company had revenue of $10.47 million for the quarter, compared to analysts’ expectations of $55.20 million. Equities analysts expect that BioStem Technologies, Inc. will post 1.41 EPS for the current year.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr.